In conclusion, our study is the first one to analyze the association between SLC2A1 expression and immune invasion, m6A modification, ferroptosis, and ceRNA regulatory network in CRC from multiple perspectives. The gene discussed is SLC2A1; the disease is colorectal carcinoma.